EXACT Sciences Corp. (EXAS)

106.87
NASDAQ : Health Technology
Prev Close 104.41
Day Low/High 104.49 / 107.61
52 Wk Low/High 53.06 / 123.99
Avg Volume 1.51M
Exchange NASDAQ
Shares Outstanding 129.49M
Market Cap 13.52B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
Exact (EXAS) Is Today's Strong On High Volume Stock

Exact (EXAS) Is Today's Strong On High Volume Stock

Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate

7 Stocks Trading on Big Volume -- but What Do the Charts Say?

7 Stocks Trading on Big Volume -- but What Do the Charts Say?

Here's a technical look at how to trade seven of the most active stocks on the market right now.

One Reason Why EXACT Sciences (EXAS) Stock Is Up Today

One Reason Why EXACT Sciences (EXAS) Stock Is Up Today

A new recommendation statement from the USPSTF boosts EXACT Sciences (EXAS) outlook and led to Canaccord Genuity raising their price target.

Exact (EXAS): Heavy Pre-Market Activity

Exact (EXAS): Heavy Pre-Market Activity

Trade-Ideas LLC identified Exact (EXAS) as a pre-market mover with heavy volume candidate

EXAS: Insiders vs. Shorts

EXAS: Insiders vs. Shorts

The most recent short interest data was recently released for the 03/31/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 11.71 "days to cover" versus the median component at 5.75.

'Mad Money' Lightning Round: Stay Away From BP

'Mad Money' Lightning Round: Stay Away From BP

Cramer prefers Whole Foods over Kroger and thinks Ford is terrific.

Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think

Jim Cramer's 'Mad Money' Recap: This Market Is Rising No Matter What You Think

Some people can't accept that things are improving, but that means the market will continue to go higher, Cramer says.

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate

Commit To Purchase EXACT Sciences Corp. At $5, Earn 21% Using Options

Commit To Purchase EXACT Sciences Corp. At $5, Earn 21% Using Options

Investors considering a purchase of EXACT Sciences Corp. stock, but cautious about paying the going market price of $7.12/share, might benefit from considering selling puts among the alternative strategies at their disposal.

EXAS: Insiders vs. Shorts

EXAS: Insiders vs. Shorts

The most recent short interest data was recently released by the NASDAQ for the 02/12/2016 settlement date, and EXACT Sciences Corp. is one of the most shorted stocks of the Russell 3000, based on 16.21 "days to cover" versus the median component at 5.27.

Here’s Why Exact Sciences (EXAS) Stock is Down Today

Here’s Why Exact Sciences (EXAS) Stock is Down Today

Exact Sciences (EXAS) stock is declining after the company reported its 2015 fourth quarter results yesterday.

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share are within range of triggering big breakouts.

EXACT Sciences is Now Oversold (EXAS)

EXACT Sciences is Now Oversold (EXAS)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Insider Trading Alert - GEVO, EXAS And CW Traded By Insiders

Insider Trading Alert - GEVO, EXAS And CW Traded By Insiders

Stocks with insider trader activity include GEVO, EXAS and CW

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Exact (EXAS) Marked As A Dead Cat Bounce Stock

Trade-Ideas LLC identified Exact (EXAS) as a "dead cat bounce" (down big yesterday but up big today) candidate

RSI Alert: EXACT Sciences (EXAS) Now Oversold

RSI Alert: EXACT Sciences (EXAS) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Exact (EXAS) Stock: Weak On High Volume Today

Exact (EXAS) Stock: Weak On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

Commit To Buy EXACT Sciences Corp. At $5, Earn 16% Using Options

Commit To Buy EXACT Sciences Corp. At $5, Earn 16% Using Options

Investors eyeing a purchase of EXACT Sciences Corp. stock, but tentative about paying the going market price of $7.84/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Exact (EXAS) Weak On High Volume

Exact (EXAS) Weak On High Volume

Trade-Ideas LLC identified Exact (EXAS) as a weak on high relative volume candidate

4 Stocks Under $10 to Trade for Big Breakouts

4 Stocks Under $10 to Trade for Big Breakouts

These stocks trading for less than $10 a share are within range of triggering breakout trades.

Exact Sciences To Participate In J.P. Morgan 2016 Healthcare Conference

Exact Sciences To Participate In J.P. Morgan 2016 Healthcare Conference

Exact Sciences Corp. (Nasdaq: EXAS) today announced that Kevin T.

Exact (EXAS) Is Strong On High Volume Today

Exact (EXAS) Is Strong On High Volume Today

Trade-Ideas LLC identified Exact (EXAS) as a strong on high relative volume candidate

5 Stocks Under $10 Set to Soar

5 Stocks Under $10 Set to Soar

These stocks trading for less than $10 a share look ready to break out and trade higher from current levels.

Exact Sciences Names John Bakewell Chief Financial Officer

Exact Sciences Names John Bakewell Chief Financial Officer

Exact Sciences Corp. (NASDAQ: EXAS) today announced the appointment of John K.

CMS Corrects 2016 Reimbursement Rate For Cologuard®

CMS Corrects 2016 Reimbursement Rate For Cologuard®

Exact Sciences Corp. (Nasdaq: EXAS) announced that the Centers for Medicare and Medicaid Services (CMS) indicated that it is correcting the 2016 Clinical Laboratory Fee Schedule (CLFS) and will include the reimbursement...

Exact Sciences Addresses CMS's 2016 Clinical Diagnostic Laboratory Fee Schedule

Exact Sciences Addresses CMS's 2016 Clinical Diagnostic Laboratory Fee Schedule

On November 25, 2015, the Centers for Medicare and Medicaid Services (CMS) posted the 2016 Clinical Diagnostic Laboratory Fee Schedule (CLFS) on its website.

Portfolio adjustments in a turbulent market

Portfolio adjustments in a turbulent market

Heres's why Cable Car added to its position in Retrophin

Exact Sciences To Participate In November Investor Conferences

Exact Sciences To Participate In November Investor Conferences

Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will participate in two investor conferences during November.

Exact Sciences Aims To Collaborate With City Of Madison & University Of Wisconsin In Developing A Biotech Campus

Exact Sciences Aims To Collaborate With City Of Madison & University Of Wisconsin In Developing A Biotech Campus

Exact Sciences Corp. (NASDAQ: EXAS) announced today that it will continue collaborating with the City of Madison in an attempt to establish a headquarters in Madison and is in discussions with the University of...

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Exact (EXAS) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas LLC identified Exact (EXAS) as a "perilous reversal" (up big yesterday but down big today) candidate

TheStreet Quant Rating: C- (Hold)